Finanzen von FibroGen Inc (FGEN)FGENFibroGen Inc

Evaluating the bottom line, FibroGen Inc maintains a gross margin of 105.39%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -499.07%, while the net margin is -1221.75%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively FGEN converts its operational activities into shareholder value.

In the context of the broader market, FGEN competes directly with industry leaders such as GBIO and VERU. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, FGEN's gross margin of 105.39% stands against GBIO's 100.00% and VERU's N/A. Such benchmarking helps identify whether FibroGen Inc is trading at a premium or discount relative to its financial performance.